This article reviews current imaging approaches in inflammatory breast carcinoma (IBC), a rare form of carcinoma with poor survival outcomes. This review emphasizes mammography, sonography, magnetic resonance imaging (MRI), technetium-99m sestamibi imaging, and positron emission tomography (PET). Also, the clinical presentations and the pathology of IBC are discussed along with current treatment approaches. In the past, imaging has been used mainly to verify the diagnosis of IBC and to help distinguish IBC from mastitis. In the future, there may be a greater role for imaging in monitoring response to treatment in the breast and in the regional lymph nodes. MRI and PET will play a major role as imaging of IBC evolves from a morphological basis to a biologic basis.
|Original language||English (US)|
|Number of pages||10|
|Journal||Seminars in Breast Disease|
|State||Published - Jan 1 2001|
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging